Chia Tai Enterprises International Limited (03839.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 18Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 18

Key dataSep 18, 2026

OpenHKD 8.41

From 52W high−14.97%

Volume40140.00

Market capHKD 2.12B

P/E (TTM)11.0x

P/S (TTM)0.6x

Div yield—

Key dataSep 18, 2026

Open

HKD 8.41

From 52W high

−14.97%

Volume

40140.00

Market cap

HKD 2.12B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

9.8x

P/E (TTM)

11.0x

RSI (14)

38.9

MomentumView details →

1D Return

−0.30%

YTD Return

+15.52%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

11.0x

EV/EBITDA

9.8x

EV/Sales

0.8x

P/S (TTM)

0.6x

P/B (TTM)

0.9x

ProfitabilityView details →

Gross Margin

16.60%

Net Margin

5.76%

EBITDA Margin

8.17%

ROE (TTM)

8.32%

ROA (TTM)

4.84%

Asset Turnover

0.86x

GrowthView details →

Revenue YoY

−18.94%

EPS YoY

−6.66%

FCF YoY

—

Revenue CAGR 3Y

+49.93%

EPS CAGR 3Y

+258.77%

EBITDA YoY

−12.16%

MomentumView details →

1D Return

−0.30%

YTD Return

+15.52%

1Y Return

−5.47%

RSI (14)

38.9

vs 50D SMA

−5.48%

vs 200D SMA

+8.11%

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

1.60x

Quick Ratio

1.36x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

HKD 0.17

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

424.03M

Net Income (TTM)

24.44M

Op. CF (TTM)

0.00

Latest newsMore news →

Zhengda Biotech announced its interim results for the six months ended June 2026, with revenue of $211 million, down 34.6% year-on-year, and net profit of $9.423 million, down 44.7% year-on-year.40d ago

Similar companies

Bausch Health Companies Inc.BHC Avadel Pharmaceuticals plcAVDL AlvotechALVO VISEN Pharmaceuticals02561.HK Jacobson Pharma Corporation Limited02633.HK HUTCHMED (China) LimitedHCM Find similar companies →

Latest newsMore news →

Zhengda Biotech announced its interim results for the six months ended June 2026, with revenue of $211 million, down 34.6% year-on-year, and net profit of $9.423 million, down 44.7% year-on-year.40d ago